96 well-plate RapidAIM assay

MedBiome’s founders reported in Nature Comms. on the development of 96-well plate approach that maintains functional and compositional profiles of individual gut microbiomes. They demonstrated strong correlation between in vitro and in vivo microbiome responses to drugs.

MedBiome participates in Bio Europe

Dr. Alain Stintzi and Dr. Daniel Figeys were at Bio Europe in Copenhagen in November 2018. They presented the RapidAIM platform to rapidly study the effects of drugs and other compounds on individual human microbiome. They also presented their therapeutic development for pediatric IBD.